Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Patients and clinicians urge Medicaid and insurers to cover GLP‑1 obesity treatments; insurers warn of high costs
Summary
The House Committee on Behavioral Health and Health Care opened an informational hearing on House Bill 3,517 to consider health‑insurance coverage for GLP‑1 and related obesity medications.
Chair (House Committee on Behavioral Health and Health Care) opened an informational hearing on health insurance coverage of GLP‑1 obesity medications under House Bill 3,517.
Patient advocates and clinicians described obesity as a chronic disease with many related conditions and asked for comprehensive coverage that includes behavioral therapies, FDA‑approved medications and surgical options. Crystal Hartman, a patient advocate from Bend, told the committee she had bariatric surgery and later required GLP‑1 treatment; when she moved to Medicaid in 2024 she lost access to her GLP‑1 and gained 40 pounds despite no change in diet or exercise. "No one with heart disease, diabetes, high blood…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
